ZDF
Sign inSign up

Vulnerabilities

Vulnerability · CVE-2025-30727

Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: iSurvey Module).

Published Apr 15, 2025 · catalog updated Feb 26, 2026 · Oracle Corporation Oracle Scripting

Check if you run it

No confirmed exploitation is on record for CVE-2025-30727. EPSS is 0.55%. Act only if a listed version of Oracle Corporation Oracle Scripting is installed.

Gaps on this record

  • No vendor fix or required action is stored. Compare the linked advisory before you change production.
Severity
Critical9.8
Known exploitation
Not in CISA/VulnCheck KEV
EPSS
0.55%
Remediation
Advisory link
Affected products
vendor Oracle Corporation Oracle Scripting 12.2.3 ≤12.2.14

Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: iSurvey Module). Supported versions that are affected are 12.2.3-12.2.14. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Scripting. Successful attacks of this vulnerability can result in takeover of Oracle Scripting. CVSS 3.1 Base Score 9.8 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:H).

Are you affected?

Enter the version you run. The result uses only the ranges stored on this record.

The check returns affected, not affected, or incomplete. It does not guess a version that is missing from the record.

  • vendor Oracle Corporation Oracle Scripting 12.2.3 ≤12.2.1412.2.3 ≤12.2.14

How to fix CVE-2025-30727

What to do

Three questions, each answered from this record only. Confirm the vendor advisory before you patch.

Should you patch?

No confirmed exploitation is on record for CVE-2025-30727. EPSS is 0.55%. Act only if a listed version of Oracle Corporation Oracle Scripting is installed.

Which versions are affected?

Compare what you have installed with Oracle Corporation Oracle Scripting 12.2.3 ≤12.2.14 12.2.3 ≤12.2.14. Compare the installed version with the linked vendor advisory before you change production.

What should an analyst verify?

No weakness class is stored. EPSS 0.55%. There is no CISA KEV listing. No Exploit-DB or Metasploit reference is linked. Use the source links for the original advisory.

Code

The project this record applies to. Exploit listings stay in References.

No public source repository is identified for this product.

Timeline

Detection, updates, and resolution for this record.

  1. Apr 15, 2025 · EUVD

    Detected

    Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: iSurvey Module). Supported versions that are affected are 12.2.3-12.2.14. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Scripting. Successful attacks of this vulnerability can result in takeover of Oracle Scripting. CVSS 3.1 Base Score 9.8 (Confi

  2. Feb 26, 2026 · EUVD

    Updated

    Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: iSurvey Module). Supported versions that are affected are 12.2.3-12.2.14. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Scripting. Successful attacks of this vulnerability can result in takeover of Oracle Scripting. CVSS 3.1 Base Score 9.8 (Confi

Sources

  • CVE.orgVulnerability recordCVE-2025-30727

    Official CVE identifier

    cve.org
  • FIRST EPSSExploitation probabilityCVE-2025-30727

    30-day exploitation probability 0.5%

    first.org
  • EUVDVulnerability recordEUVD-2025-11024

    Vulnerability in the Oracle Scripting product of Oracle E-Business Suite (component: iSurvey Module). Supported versions that are affected are 12.2.3-12.2.14. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Script

    euvd.enisa.europa.eu

References

Freshness

Last verified in this catalog Oct 18, 2026. Significant claims (KEV, EPSS, CVSS, affected ranges) come from the source rows above — open the original publisher for the authoritative advisory.